NLK Is a Novel Therapeutic Target for PTEN Deficient Tumour Cells

PTEN (Phosphatase and tensin homolog) is a tumour suppressor gene commonly defective in human cancer, and is thus a potentially important therapeutic target. Targeting tumour suppressor loss-of-function is possible by exploiting the genetic concept of synthetic lethality (SL). By combining the use o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes-Pereira, Ana M., Lord, Christopher J., Ashworth, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483146/
https://www.ncbi.nlm.nih.gov/pubmed/23144700
http://dx.doi.org/10.1371/journal.pone.0047249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483146/
https://www.ncbi.nlm.nih.gov/pubmed/23144700
http://dx.doi.org/10.1371/journal.pone.0047249

Ejemplares similares